Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

Cited by (1,000)

Items 201–300 of 1,000

1. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial
   Sulman Rafiq, Daniel Andreas Steinbrüchel, Nikolaj Bang Lilleør, Christian Holdflod Møller, Jens Teglgaard Lund, Jens Juel Thiis, Lars Køber, Peter Skov Olsen · 2016 · Thrombosis Research
2. Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
   Paul L. Hess, Michael J. Mirro, Hans‐Christoph Diener, John W. Eikelboom, Sana M. Al‐Khatib, Elaine M. Hylek, Hayden Barry Bosworth, Bernard John Gersh, Daniel E. Singer, Greg Flaker et al. · 2014 · American Heart Journal
3. Current and Emerging Direct Oral Anticoagulants: State-of-the-Art
   Giuseppe Lippi, Robert C. Gosselin, Emmanuel J. Favaloro · 2019 · Seminars in Thrombosis and Hemostasis
4. The Ross procedure offers excellent survival compared with mechanical aortic valve replacement in a real-world setting
   Martin Andreas, Dominik Wiedemann, Gernot Seebacher, Claus Rath, Tandis Aref, Raphaël Rosenhek, Georg Heinze, Ernst Eigenbauer, Paul Simon, Kurt Ruetzler et al. · 2014 · European Journal of Cardio-Thoracic Surgery
5. Contact System Activation and Cancer: New Insights in the Pathophysiology of Cancer-Associated Thrombosis
   Elena Campello, Michael Wayne Henderson, Denis F. Noubouossie, Paolo Simioni, Nigel S. Key · 2018 · Thrombosis and Haemostasis
6. Pathophysiology of thrombosis and anticoagulation post Fontan surgery
   Chantal Attard, Joanna Yilin Huang, Paul Monagle, Vera Ignjatović · 2018 · Thrombosis Research
7. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
   Gregory Y.H. Lip, Jean‐Philippe Collet, Raffaele De Caterina, Laurent Fauchier, Deirdre A. Lane, Torben Bjerregaard Larsen, Francisco R. Marín, João Morais, Calambur Narasimhan, Brian Olshansky et al. · 2017 · Thrombosis and Haemostasis
8. Achieving Totally Local Anticoagulation on Blood Contacting Devices
   Rana Gbyli, Anna Mercaldi, Harihara S. Sundaram, Kagya A. Amoako · 2017 · Advanced Materials Interfaces
9. Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “rubber effect”
   Panayiotis D. Ziakas, Irene S. Kourbeti, Loukia S. Poulou, Georgios S. Vlachogeorgos, Eleftherios E Mylonakis · 2018 · PLoS ONE
10. Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick
    Job Harenberg, Rupert Schreiner, Svetlana Hetjens, Christel Weiß · 2018 · Seminars in Thrombosis and Hemostasis
11. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system
    Ryan A. Watson, Drew M. Johnson, Robin N. Dharia, Geno J. Merli, John U. Doherty · 2020 · Hospital Practice
12. Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study
    André Rodrigues Durães, Yasmin de Souza Lima Bitar, Igor Santos Schonhofen, Kethyren Santos Oliveira Travassos, Larissa Vitória Pereira, José Admirço Lima Filho, Mansueto Gomes Neto, Roque Aras, Leonardo Roever · 2020 · American Journal of Cardiovascular Drugs
13. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis
    Thomas Mark Beaver, Joseph E. Bavaria, Bartley P. Griffith, Lars Georg Svensson, Philippe Pîbarot, Michael Andrew Borger, Omar M. Sharaf, David A. Heimansohn, Vinod H. Thourani, Eugene H. Blackstone et al. · 2023 · Journal of Thoracic and Cardiovascular Surgery
14. Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device
    Alanna A. Morris, Ann Pekarek, Kris Wittersheim, Robert Townsend Cole, Divya Gupta, Duc Nguyen, S. Raja Laskar, Javed Butler, Andrew Paul Smith, John David Vega · 2015 · The Journal of Heart and Lung Transplantation
15. Antithrombotic therapy management of adult and pediatric cardiac surgery patients
    Lisa Baumann Kreuziger, Keyvan Karkouti, James S. Tweddell, Mary Patricia Massicotte · 2018 · Journal of Thrombosis and Haemostasis
16. Anticoagulation with VADs and ECMO: walking the tightrope
    Leslie J. Raffini · 2017 · Hematology
17. Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues
    Fiona Helen Newall, Brian R. Branchford, Christoph Male · 2018 · Journal of Thrombosis and Haemostasis
18. Thromboembolic and Bleeding Complications in Transcatheter Aortic Valve Implantation: Insights on Mechanisms, Prophylaxis and Therapy
    Mark P. Ranasinghe, Karlheinz Peter, James D. McFadyen · 2019 · Journal of Clinical Medicine
19. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves
    Vincenzo Russo, Andreina Carbone, Emilio Attena, Anna Rago, Carmine Mazzone, Riccardo Proietti, Valentina Parisi, Andrea Scotti, Gerardo Nigro, Paolo Golino et al. · 2019 · Clinical Therapeutics
20. Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
    Alaide Chieffo, Dariusz Dudek, Christian Hassager, Alain Combes, Mario Gramegna, Sigrun Halvorsen, Kurt Huber, Vijay Kunadian, Jiří Malý, Jacob Eifer Møller et al. · 2021 · EuroIntervention
21. Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target
    John W. Eikelboom, Jürgen Floege, Ravi Thadhani, Jeffrey Ian Weitz, Wolfgang C. Winkelmayer­ · 2021 · Kidney International
22. Oral Anticoagulants Beyond Warfarin
    Renske H. Olie, Kristien Winckers, Bianca Rocca, Hugo Ten Cate · 2023 · The Annual Review of Pharmacology and Toxicology
23. Novel anticoagulants: general overview and practical considerations for dental practitioners
    S Elad, J Marshall, Cyril Meyerowitz, G Connolly · 2015 · Oral Diseases
24. On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation
    Mika Skeppholm, Paul Hjemdahl, Jovan P. Antović, Josephine Muhrbeck, Jaak Eintrei, Yuko Rönquist-Nii, Anton Pohanka, Olof Beck, Rickard E. Malmström · 2014 · Thrombosis Research
25. Quality of Anticoagulation With Warfarin at a Tertiary Hospital in Botswana
    J. Mwita, J. Francis, A. Oyekunle, Marea Gaenamong, M. Goepamang, M. Magafu · 2017 · Clinical and applied thrombosis/hemostasis
26. An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device
    Ian B. Hollis, Douglas L. Jennings, Selim R. Krim, Van‐Khue Ton, Anique Ducharme, Jennifer Ann Cowger, Mary Looby, J J Eulert-Green, Neha Bansal, Ed Horn et al. · 2024 · The Journal of Heart and Lung Transplantation
27. Secondary Ischemic Stroke Prevention
    Aaron Bangad, Mehdi Abbasi, Adam de Havenon · 2023 · Neurotherapeutics
28. Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding.
    Truman John Milling, Jennifer Ann Frontera · 2017 · PubMed
29. Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías
    Helmut Baumgartner, Volkmar Falk, Jeroen Joost Bax, Michele De Bonis, Christian W. Hamm, Per Johan Holm, Bernard Iung, Patrizio Lancellotti, Emmanuel Lansac, Daniel Rodríguez Muñoz et al. · 2018 · Revista Española de Cardiología
30. Anticoagulation strategies in extracorporeal circulatory devices in adult populations
    Catherine M. Kato, Michael Oakes, Morris Kim, Anish Desai, Sven Reid Olson, Vikram M. Raghunathan, Joseph James Shatzel · 2020 · European Journal Of Haematology
31. Anticoagulation in adults with congenital heart disease: The who, the when and the how?
    Annette Schophuus Jensen, Lars Idorn, Betina Nørager, Niels Grove Vejlstrup, Lars Søndergaard · 2014 · Heart
32. JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
    Takeshi Kitai, Shun Kohsaka, Takao Kato, Eri Toda Kato, Kimi Sato, KANAKO TERAMOTO, Hidenori Yaku, Eiichi Akiyama, Masahiko Ando, Chisato Izumi et al. · 2025 · Journal of Cardiac Failure
33. Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants
    Heinrich Koertke, Armin Zittermann, Otto Wagner, Songuel Secer, Christ of Huth, A. Sciangula, W. Saggau, F.-U. Sack, J. Ennker, Jochen Cremer et al. · 2014 · European Heart Journal
34. Pharmacology and mechanisms of action of new oral anticoagulants
    Joe‐Elie Salem, Pierre François Sabouret, Christian Funck‐Brentano, Jean‐Sébastien Hulot · 2014 · Fundamental and Clinical Pharmacology
35. The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines
    Laurent Macle, John A. Cairns, Jason G. Andrade, L. Brent Mitchell, Stanley Nattel, Atul Verma, Atul Verma, Laurent Macle, Jason G. Andrade, Clare L. Atzema et al. · 2015 · Canadian Journal of Cardiology
36. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis
    Bartosz Grzymala-Lubanski, Peter J Svensson, Henrik Renlund, Anders Jeppsson, Anders Själander · 2016 · Heart
37. Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation
    Darae Ko, Christina L. Cove, Elaine M. Hylek · 2014 · Thrombosis and Haemostasis
38. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants
    Graeme J. Hankey · 2013 · Thrombosis and Haemostasis
39. Bleeding in critical care associated with left ventricular assist devices: pathophysiology, symptoms, and management
    Frank W.G. Leebeek, Rahatullah Muslem · 2019 · Hematology
40. Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction
    Yoshinori Mano, Kimi Koide, Hiroaki Sukegawa, Masaki Kodaira, Takahiro Ohki · 2014 · Heart and Vessels
41. Peri-procedural management of patients taking oral anticoagulants
    Paul R. Daniels · 2015 · BMJ
42. Chinese guidelines for the diagnosis and management of atrial fibrillation
    Changsheng Ma, Shulin Wu, Shaowen Liu, Yaling Han · 2024 · Pacing and Clinical Electrophysiology
43. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary
    Paul Khairy, George F. Van Hare, Seshadri Balaji, Charles I. Berul, Frank Cecchin, Mitchell I. Cohen, Curt J. Daniels, Barbara J. Deal, Joseph A. Dearani, Natasja M. S. de Groot et al. · 2014 · Heart Rhythm
44. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial
    Raffaele De Caterina, A. John Camm · 2015 · EP Europace
45. Current challenges and future prospects in oral anticoagulant therapy
    Julia Czuprynska, Jignesh Prakash Patel, Roopen Arya · 2017 · British Journal of Haematology
46. Novel oral anticoagulant use in adult Fontan patients: A single center experience
    Justin Georgekutty, Amir Kazerouninia, Yunfei Wang, Peter Ryan Ermis, Dhaval R. Parekh, Wayne Franklin, Wilson Lam · 2018 · Congenital Heart Disease
47. JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
    Ono K, Yu‐ki Iwasaki, Masaharu Akao, Takanori Ikeda, Kuniaki Ishii, Yasuya Inden, Kengo Kusano, Yoshinori Kobayashi, Yukihiro Koretsune, Tetsuo Sasano et al. · 2022 · Journal of Arrhythmia
48. Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis
    Tobias Petzold, Manuela Thienel, Ildiko Konrad, Irene Schubert, Ron Regenauer, Boj Friedrich Hoppe, Michael C. Lorenz, Annekathrin Eckart, Sue Chandraratne, Carsten Lennerz et al. · 2016 · Science Translational Medicine
49. Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
    Konstantinos N. Aronis, Elaine M. Hylek · 2018 · Journal of the American Heart Association
50. Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves
    Alberto Aimo, Robert Patrick Giugliano, Raffaele De Caterina · 2018 · Circulation
51. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?
    Benjamin Cross, Richard Myles Turner, Eunice J. Zhang, Munir Pirmohamed · 2024 · The Pharmacogenomics Journal
52. Advances in stroke prevention
    Ayesha Z. Sherzai, Mitchell S.V. Elkind · 2015 · Annals of the New York Academy of Sciences
53. Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis
    Raphaël Philippart, Anne Brunet-Bernard, Nicolas Clémenty, Thierry Bourguignon, Alain Mirza, Denis Angoulvant, Dominique Babuty, Gregory Y.H. Lip, Laurent Fauchier · 2016 · Thrombosis and Haemostasis
54. 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis
    Jeffrey Ian Weitz, James C. Fredenburgh · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
55. Direct oral anticoagulants: a review of common medication errors
    Drakeria Barr, Quovadis J. Epps · 2018 · Journal of Thrombosis and Thrombolysis
56. Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves
    Aaqib Habib Malik, Srikanth Yandrapalli, Wilbert S. Aronow, Julio A. Panza, Howard A. Cooper · 2019 · Heart
57. Atrial Fibrillation
    Sana M. Al‐Khatib · 2023 · Annals of Internal Medicine
58. Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis
    Zien Zhou, Jie Yu, Cheryl Carcel, Candice Delcourt, Jiehui Shan, Richard I. Lindley, Bruce Charles Neal, Craig S. Anderson, Maree Lisa Hackett · 2018 · BMJ Open
59. Progress in the monitoring of direct oral anticoagulant therapy
    Jignesh Prakash Patel, Rosalind Byrne, Raj Patel, Roopen Arya · 2019 · British Journal of Haematology
60. The Global Impact of Rheumatic Heart Disease
    Joselyn Rwebembera, Andrea Beaton, Sarah R. de Loizaga, Rodrigo Tavares Lanna Rocha, Doreen Nakagaayi, Isaac Ssinabulya, Emmy Okello, Clara L. Fraga, Bruno Fernandes Galdino, Maria Carmo Pereira Nunes et al. · 2021 · Current Cardiology Reports
61. Heart–Brain Relationship in Stroke
    Roger E. Kelley, Brian Patrick Kelley · 2021 · Biomedicines
62. Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device
    Leif Bösche, Faegheh Afshari, Dominik Schöne, Aydan Ewers, Andreas Mügge, Michael Gotzmann · 2015 · Clinical Cardiology
63. Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin
    Khagendra B. Dahal, Sharan Prakash Sharma, Erik Fung, Juyong Lee, Jason H. Moore, John N. Unterborn, Scott M. Williams · 2015 · CHEST Journal
64. Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices
    Lisa Baumann Kreuziger · 2014 · Journal of Thrombosis and Thrombolysis
65. Non–vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing
    Jared P. Beller, Elizabeth D. Krebs, Robert B. Hawkins, James Hunter Mehaffey, Mohammed A. Quader, Alan M. Speir, Andy C. Kiser, Mark Joseph, Leora T. Yarboro, Nicholas R. Teman et al. · 2019 · Journal of Thoracic and Cardiovascular Surgery
66. Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías
    Alec S. Vahanian, Friedhelm Beyersdorf, Fabien Praz, Milan Milojevic, Stephan Ernst Baldus, Johann K Bauersachs, Davide Capodanno, Lenard Conradi, Michele De Bonis, Ruggero De Paulis et al. · 2022 · Revista Española de Cardiología
67. Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review
    Tagore Sunkara, Emmanuel Ofori, Vadim Zarubin, Megan E. Caughey, Vinaya V. Gaduputi, Madhavi Reddy · 2016 · Health Services Insights
68. Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
    Ting‐Yung Chang, Jo‐Nan Liao, Tze‐Fan Chao, Jennifer Jeanne B. Vicera, Chin‐Yu Lin, Ta‐Chuan Tuan, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu et al. · 2018 · IJC Heart & Vasculature
69. Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model
    Patrick A. Lester, Dawn M. Coleman, Jose Antonio Diaz, Tatum Jackson, Angela E. Hawley, Angela R. Mathues, Brandon T. Grant, Robert M. Knabb, Eduardo Ramacciotti, Charles E. Frost et al. · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
70. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis
    Daniel Caldeira, Cláudio David, João N. Costa, Joaquim José Ferreira, Fausto José Pinto · 2017 · European Heart Journal - Cardiovascular Pharmacotherapy
71. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating ‘valvular heart disease’ in a nationwide cohort study
    Gregory Y.H. Lip, Martin Jensen, Line Melgaard, Flemming Skjøth, Peter Brønnum Nielsen, Torben Bjerregaard Larsen · 2018 · EP Europace
72. Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!
    Katherine Cashen, Kathleen L. Meert, Heidi J. Dalton · 2019 · Frontiers in Pediatrics
73. Development of a system to support warfarin dose decisions using deep neural networks
    Heemoon Lee, Hyun Joo Kim, Hyoung Woo Chang, Dong Jung Kim, Jonghoon Mo, Ji-Eon Kim · 2021 · Scientific Reports
74. Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants
    Walter Ageno, Bruno Caramelli, Marco Paolo Donadini, Laura Girardi, Nicoletta Riva · 2024 · The Lancet Haematology
75. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant
    Daniel C. Wadsworth, Emma Sullivan, Thomas Jacky, Taylor Sprague, Hannah Feinman, Jennifer Kim · 2021 · Journal of Clinical Pharmacy and Therapeutics
76. 2025 Clinical practice guidelines for Atrial fibrillation and flutter
    Elena Zelikovna Golukhova, Golitsyn Sp, Е. Н. Михайлов, A.S.h. Revishvili, Mari G. Arakelyan, E. Yu. Vasilyeva, Karapet V. Davtyan, Oksana M. Drapkina, L. Yu. Drozdova, Кропачева Екатерина Станиславовна et al. · 2026 · Russian Journal of Cardiology
77. Management of Dabigatran‐Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis
    Kaylee K. Marino, Raul A. Santiago, Richard B. Dew, Nancy Berliner, Jean M. Connors, Nathan T. Connell, John Kevin Tucker · 2016 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
78. What Surgeons Should Know About Non–Vitamin K Oral Anticoagulants
    Atul Verma, Andrew C.T. Ha, James T. Rutka, Subodh Verma · 2018 · JAMA Surgery
79. Non-vitamin K antagonist oral anticoagulants (NOACs): clinical evidence and therapeutic considerations
    Karan Saraf, Paul Morris, Pankaj Garg, Paul J. Sheridan, Robert F. Storey · 2014 · Postgraduate Medical Journal
80. Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage
    Jochen A. Sembill, Joji B. Kuramatsu, Stefan Schwab, Hagen B. Huttner · 2019 · Neurological Research and Practice
81. Characteristics of surgical prosthetic heart valves and problems around labeling: A document from the European Association for Cardio-Thoracic Surgery (EACTS)—The Society of Thoracic Surgeons (STS)—American Association for Thoracic Surgery (AATS) Valve Labelling Task Force
    Andras Peter Durko, Stuart J. Head, Philippe Pîbarot, Pavan Atluri, Vinayak Bapat, Duke Edward Cameron, Filip P A Casselman, Edward P. Chen, Gry Dahle, Tjark Ebels et al. · 2019 · Journal of Thoracic and Cardiovascular Surgery
82. Anticoagulant treatment and bleeding complications in patients with left ventricular assist devices
    Paul L. den Exter, Saskia L.M.A. Beeres, Jeroen C.J. Eikenboom, Frederikus Albertus Klok, Menno Volkert Huisman · 2020 · Expert Review of Cardiovascular Therapy
83. Predictors of Use and Outcomes of Mechanical Valve Replacement in the United States (2008–2017)
    Mohamad Adnan Alkhouli, Fahad Alqahtani, Trevor Simard, Sorin V. Pislaru, Hartzell Vernon Schaff, Rick A. Nishimura · 2021 · Journal of the American Heart Association
84. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
    Xiaoqin Wang, Yanfang Ma, Hui Xu, Meixuan Li, Jing Li, Jinhui Tian, Qi Wang, Peijing Yan, Jianfeng Li, Ping Xie et al. · 2023 · Cochrane Database of Systematic Reviews
85. DOACs: role of anti-Xa and drug level monitoring
    Siraj Mithoowani, Deborah M. Siegal · 2024 · Hematology
86. Practical aspects of new oral anticoagulant use in atrial fibrillation
    Anetta Undas, Tomasz Pasierski, Jerzy Windyga, Mark Andrew Crowther · 2014 · Polskie Archiwum Medycyny Wewnętrznej
87. Long-Term Results of Aortic Valve Replacement With Mechanical Prosthesis or Carpentier-Edwards Perimount Bioprosthesis in Japanese Patients According to Age
    Takahiro Nishida, Hiromichi Sonoda, Yasuhisa Oishi, Hideki Tatewaki, Yoshihisa Tanoue, Yuichi Shiokawa, Ryuji Tominaga · 2014 · Circulation Journal
88. Challenges and Priorities for Research
    Brian W. McCrindle, Jennifer S. Li, Cedric Manlhiot, James S. Tweddell, Therese M. Giglia, Mary Patricia Massicotte, Paul Monagle, Rajesh Krishnamurthy, Kenneth W. Mahaffey, Alan D. Michelson et al. · 2014 · Circulation
89. Evaluation of Dabigatran Bleeding Adverse Reaction Reports in the FDA Adverse Event Reporting System during the First Year of Approval
    Kevin W. McConeghy, Adam Phillip Bress, Dima Mazen Qato, Coady Wing, Edith A. Nutescu · 2014 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
90. Who, when, and how to reverse non-vitamin K oral anticoagulants
    Konstantinos N. Aronis, Elaine M. Hylek · 2015 · Journal of Thrombosis and Thrombolysis
91. Current Evidence-Based Understanding of the Epidemiology, Prevention, and Treatment of Atrial Fibrillation
    Paul A. Rogers, Michael L. Bernard, Christopher A. Madias, Sudarone Thihalolipavan, N.A. Mark Estes, Daniel P. Morin · 2017 · Current Problems in Cardiology
92. Mechanical heart valve prosthesis and warfarin – Treatment quality and prognosis
    Bartosz Grzymala-Lubanski, Ashkan Labaf, Erling Englund, Peter J Svensson, Anders Själander · 2014 · Thrombosis Research
93. Thromboembolism in pregnancy: Challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves
    Claire McLintock · 2014 · Best Practice & Research Clinical Obstetrics & Gynaecology
94. Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry
    Sreekanth Vemulapalli, David R. Holmes, David Dai, Roland Matsouaka, Michael J. Mack, Fred L. Grover, Raj Makkar, Vinod H. Thourani, Pamela S. Douglas · 2017 · American Heart Journal
95. Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors
    Nûn Kalim Bentounes, Sophie Melicine, Anne‐Céline Martin, David M. Smadja, Nicolas Gendron · 2023 · JMV-Journal de Médecine Vasculaire
96. Anticoagulation Strategies for the Management of Postoperative Atrial Fibrillation
    Eric Jon Anderson, Cornelius Dyke, Jerrold H. Levy · 2014 · Clinics in Laboratory Medicine
97. Anticoagulation in neonatal ECMO
    Aditi Kamdar, Natalie E. Rintoul, Leslie J. Raffini · 2018 · Seminars in Perinatology
98. The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations
    Raffaele De Caterina, Walter Ageno, Giancarlo Agnelli, Noel Chan, Hans‐Christoph Diener, Elaine M. Hylek, Gary E. Raskob, Deborah M. Siegal, Freek W.A. Verheugt, Gregory Y.H. Lip et al. · 2018 · Thrombosis and Haemostasis
99. In situ regeneration of bioactive coatings enabled by an evolved Staphylococcus aureus sortase A
    Hyun Ok Ham, Zheng Qu, Carolyn A. Haller, Brent M. Dorr, Erbin Dai, Wookhyun Kim, David R. Liu, Elliot L. Chaikof · 2016 · Nature Communications
100. Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease
     Eman Abdelghani, Clifford L. Cua, Jean Giver, Vilmarie Rodriguez · 2021 · Cardiology and Therapy